Codex Labs Introduces the BIA Skin Barrier Support Supplement for Eczema-Prone Infants, Toddlers and Kids under 12Codex Labs launches BIA Skin Barrier Support Supplements for eczema-prone infants, toddlers, and kids under 12, based on a license of patents from Curapel, a UK skin healthcare company. . The supplements provide amino acid L-Histidine and aim to fortify the skin barrier and reduce sensitivity. A Curapel clinical pilot study showed a 49% improvement in eczema severity after 12 weeks. The products are manufactured in a cGMP facility and third-party tested.
Codex Labs Shaant ClearSkin Probiotic 2.0 Supplement for Oily and Acne-Prone Skin Is Awarded U.S. PatentOpen-Label Clincal Study Results for Codex Labs Shaant ClearSkin Probiotic 2.0 Supplement Published in Dermatology and Therapy and Illustrate the Gut-Skin Relationship in Acne
Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiomeSan Jose, CA, USA, April 08, 2025 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley skintech company, announced that its over-the-counter (OTC) Bia Eczema Relief Lotion has been awarded the Seal of Acceptance by the National Eczema Association (NEA). The NEA Seal of Acceptance™ highlights products that avoid ingredients known to irritate and that are suitable for care of eczema or sensitive skin.
